$2.5m medicine is ‘game-changer’ for infants with genetic disorder – BBC News

BBC News published this video item, entitled “$2.5m medicine is ‘game-changer’ for infants with genetic disorder – BBC News” – below is their description.

A baby boy has become one of the first patients to be treated on the UK’s NHS with Zolgensma, the world’s most expensive medicine.

Little Arthur is one of around 40 children are born with the most severe form of Spinal Muscular Atrophy (SMA) every year.

The gene therapy has a list price of about $2.5m and is manufactured by Novartis Gene Therapies.

BBC News YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - BBC News

The video item below is a piece of English language content from BBC News. The British Broadcasting Corporation (BBC) is a British public service broadcaster funded by the UK Government, and British license fee payers. Its headquarters are at Broadcasting House in Westminster, London.

Recent from BBC News:

  • ‘I care about climate change – but my dad works in the oil industry’ – BBC News
  • Whirling dancer’s escape from Afghanistan – BBC News
  • The homemakers breaking taboos on Instagram
  • In This Story: Novartis

    Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales.

    2 Recent Items: Novartis

  • Novartis CEO: Demand has surged for therapeutics
  • Novartis CEO on development of AI tech in health care
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.